Featured News - Current News - Archived News - News Categories

UB pharmacy, NYSDOH partner to create new opioid prescriber training program


Fri, Mar 31st 2017 06:35 pm

The University at Buffalo School of Pharmacy and Pharmaceutical Sciences Office of Continuing Pharmacy Education, through a collaborative agreement with the New York State Department of Health, has created an opioid prescriber training program to help licensed prescribers within the state meet legislatively mandated educational requirements.

The program, now available to all prescribers in New York, offers training in pain management, palliative care and addiction. The training is required by June 30 for prescribers with a Drug Enforcement Administration number, and medical residents prescribing under a facility DEA number.

This program builds on an existing initiative providing opioid education to prescribers through the SUNY NYSDOH Medicaid Prescriber Education Program.

"We are very pleased to be able to offer this Accreditation Council for Continuing Medical Education-accredited training at no cost to prescribers across New York state. All participants who successfully complete this course will satisfy the training requirements set out by the state," said Edward M. Bednarczyk, Pharm.D., clinical associate professor and chair of the UB department of pharmacy practice. "We feel that educational efforts such as this will be a significant part of the effort to end the opioid epidemic that New York and the country are facing."

The first part of the series, which is available at www.pharmacy.buffalo.edu/opioid-training, focuses on pain management, management of acute pain and appropriate prescribing, as well as state and federal requirements for prescribing controlled substances. The second part, scheduled to launch on April 15, explores prevention, screening and signs of addiction, response to abuse and addiction, palliative medicine and end-of-life care.

The opioid prescriber training program is part of the New York State Prescription Drug Overdose Prevention Program, which aims to advance and evaluate comprehensive state-level interventions for preventing prescription drug overuse, misuse, abuse and overdose.

The program is made possible through the support of the Centers for Disease Control and Prevention and NYSDOH.

The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is a leader in the education of pharmacists and pharmaceutical scientists, renowned for innovation in clinical practice and research. The school is accredited by the American Council of Pharmaceutical Education and ranked as one of the top 25 schools of pharmacy and pharmaceutical sciences in the U.S.

For more information, visit:

comments powered by Disqus

Hometown News